Skip to content

Clinical trials

Pathologic Processes trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Country / region: Poland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20142
20151
20211
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zealand Pharma2
Collegium Medicum w Bydgoszczy1
Eli Lilly and Company1
Grifols Therapeutics LLC1
KAI Pharmaceuticals1
Medical University of Warsaw1
Medinice S.A.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes9
Cardiovascular Diseases3
Heart Diseases3
Digestive System Diseases2
Gastrointestinal Diseases2
Infarction2
Intestinal Diseases2
Lung Diseases2
Malabsorption Syndromes2
Myocardial Infarction2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.